⸺ Celvora
GLOW
Research blend combining BPC-157 (10mg), TB-500 (10mg) and GHK-Cu (50mg) in a single vial — studied for tissue repair and skin pathways.
Secure checkout. Free shipping on orders over £100.
Independently tested
COA on request
Fast dispatch
Order before 2pm
Research use only
Not for human consumption
⸺ Overview
About GLOW
GLOW combines BPC-157, TB-500 and the copper tripeptide GHK-Cu in a single research preparation.
⸺ Mechanism of Action
How it works
The three peptides target complementary recovery and regenerative pathways in preclinical models.
⸺ Research
Areas of study
Soft-tissue repair
BPC-157 and TB-500 improve tendon, ligament and muscle repair.
Skin and collagen biology
GHK-Cu research shows enhanced collagen and elastin synthesis.
Angiogenesis and recovery
All three peptides associated with microvascular formation.
⸺ Details
Specification
- CAS
- Blend
- Intended use
- Research use only.
- Storage
- Lyophilised: cool, dry.
- Solubility
- Vial holds up to 3mL.
- Shelf life
- Lyophilised: 24 months.
- Handling
- Sterile technique.
You might also research
View all →
Retatrutide
Investigational triple receptor agonist targeting GLP-1, GIP and glucagon — studied for appetite control, energy expenditure and glucose balance.
Tirzepatide
Dual GLP-1 and GIP receptor agonist studied in preclinical models for glucose regulation, insulin sensitivity and energy balance.
Semaglutide
Synthetic analogue of the GLP-1 hormone used in research to study glucose regulation, insulin secretion and the incretin response.